{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:50:09Z","timestamp":1789725009302,"version":"4.0.1"},"reference-count":128,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.expneurol.2010.03.018","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T17:27:54Z","timestamp":1269970074000},"page":"3-14","source":"Crossref","is-referenced-by-count":129,"title":["The endocannabinoid system and psychiatric disorders"],"prefix":"10.1016","volume":"224","author":[{"given":"Daniela","family":"Parolaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Realini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Vigano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Guidali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2010.03.018_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00213-009-1532-5","article-title":"Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats","volume":"205","author":"Aguiar","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2010.03.018_bib2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.expneurol.2010.03.018_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1471-4159.2007.05149.x","article-title":"BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice","volume":"105","author":"Aso","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.03.018_bib4","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/sj.npp.1301344","article-title":"Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis","volume":"32","author":"Ballmaier","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib5","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib7","series-title":"Program No. 60.7\/N21. 2009 Neuroscience Meeting Planner","article-title":"Depression-like phenotype following chronic treatment with rimonabant: A link between CB1 receptors and mood disorders","author":"Beyer","year":"2009"},{"key":"10.1016\/j.expneurol.2010.03.018_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00213-004-1941-4","article-title":"The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague\u2013Dawley rats","volume":"177","author":"Bortolato","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2010.03.018_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress","volume":"62","author":"Bortolato","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","article-title":"Models of schizophrenia in humans and animals based on inhibition of NMDA receptors","volume":"32","author":"Buben\u00edkov\u00e1-Valesov\u00e1","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2010.03.018_bib11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","article-title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-o-methyltransferase gene: longitudinal evidence of a gene X environment interaction","volume":"57","author":"Caspi","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajmg.b.30592","article-title":"Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia","volume":"147","author":"Chavarria-Siles","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.expneurol.2010.03.018_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-511X-2-5","article-title":"Endocannabinoid signalling in the blood of patients with schizophrenia","volume":"2","author":"De Marchi","year":"2003","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.expneurol.2010.03.018_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","article-title":"Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use","volume":"103","author":"Dean","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.03.018_bib128","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1523\/JNEUROSCI.23-06-02371.2003","article-title":"Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus","volume":"23","author":"Derkinderen","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.neuropharm.2008.08.039","article-title":"Auditory gating in rat hippocampus and medial prefrontal cortex: effect of the cannabinoid agonist WIN55, 212-2","volume":"55","author":"Dissanayake","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.euroneuro.2008.05.003","article-title":"Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression","volume":"18","author":"Domschke","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/187152707780619353","article-title":"Adult hippocampal neurogenesis as target for the treatment of depression","volume":"6","author":"Drew","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.expneurol.2010.03.018_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00406-009-0024-2","article-title":"Cannabis and psychosis\/schizophrenia: human studies","volume":"259","author":"D'Souza","year":"2009","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib19","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","article-title":"Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia","volume":"65","author":"Eggan","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevNeurobiol.v14.i1.10","article-title":"Cognitive impairment in schizophrenia is the core of the disorder","volume":"14","author":"Elvevag","year":"2000","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2007.01.009","article-title":"Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies","volume":"559","author":"Ferrer","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib24","article-title":"Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance","author":"Finn","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","article-title":"The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)","volume":"15","author":"Fraser","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2010.03.018_bib26","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.expneurol.2010.03.018_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.03.018_bib28","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2010.03.018_bib29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.mcn.2008.05.001","article-title":"A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner","volume":"38","author":"Goncalves","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0014-2999(98)00851-6","article-title":"Chronic (\u2212)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats","volume":"365","author":"Gorriti","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pbb.2005.02.004","article-title":"Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion","volume":"81","author":"Gorriti","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2010.03.018_bib32","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.neubiorev.2008.03.004","article-title":"Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders","volume":"32","author":"Gorzalka","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2010.03.018_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","article-title":"Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents","volume":"57","author":"Griebel","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib34","first-page":"1","article-title":"Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine","volume":"3","author":"Guidali","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib35","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1046\/j.1460-9568.2000.00217.x","article-title":"Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations","volume":"12","author":"Hajos","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib36","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.biopsych.2007.12.005","article-title":"Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia","volume":"63","author":"Hajos","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/09595230412331324554","article-title":"Cannabis use and psychotic disorders: an update","volume":"23","author":"Hall","year":"2004","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.expneurol.2010.03.018_bib38","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1460-9568.2002.02192.x","article-title":"The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety","volume":"16","author":"Haller","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib39","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1460-9568.2004.03293.x","article-title":"Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice","volume":"19","author":"Haller","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00008877-200509000-00014","article-title":"Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia","volume":"16","author":"Haller","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00213-009-1494-7","article-title":"Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats","volume":"204","author":"Haller","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2010.03.018_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2007.05.005","article-title":"The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia","volume":"18","author":"Hamdani","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib44","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/schbul\/sbi027","article-title":"The environment and schizophrenia: the role of cannabis use","volume":"31","author":"Henquet","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.expneurol.2010.03.018_bib45","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1038\/sj.npp.1301197","article-title":"An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition","volume":"31","author":"Henquet","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib46","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.schres.2009.04.001","article-title":"The association between early cannabis use and psychotic-like experiences in a community adolescent sample","volume":"112","author":"Hides","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.expneurol.2010.03.018_bib47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00008877-200509000-00006","article-title":"Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?","volume":"16","author":"Hill","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib48","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","article-title":"Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test","volume":"15","author":"Hill","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib49","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/187152709789824624","article-title":"The endocannabinoid system and the treatment of mood and anxiety disorders","volume":"8","author":"Hill","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.expneurol.2010.03.018_bib50","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.npp.1300601","article-title":"Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress","volume":"30","author":"Hill","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib51","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1460-9568.2006.05061.x","article-title":"Endocannabinoids modulate stress-induced suppression of hippocampal cell proliferation and activation of defensive behaviours","volume":"24","author":"Hill","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib52","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment","volume":"106","author":"Hill","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.03.018_bib53","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","article-title":"Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress","volume":"34","author":"Hill","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.npp.1300568","article-title":"CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors","volume":"30","author":"Houchi","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.mp.4001376","article-title":"Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims","volume":"9","author":"Hungund","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib56","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1172\/JCI25509","article-title":"Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects","volume":"115","author":"Jiang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2010.03.018_bib57","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/npp.2009.19","article-title":"CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms","volume":"34","author":"Juhasz","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib58","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00702-007-0660-5","article-title":"Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression","volume":"114","author":"Koethe","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2010.03.018_bib59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.phrs.2007.09.006","article-title":"The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction","volume":"56","author":"Lafenetre","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.expneurol.2010.03.018_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2010.03.018_bib61","first-page":"310","article-title":"Double blind, controlled clinical trial of cannabidiol monotherapy versus amisulpiride in the treatment of acutely psychotic schizophrenia patients","volume":"33","author":"Leweke","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.expneurol.2010.03.018_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","article-title":"Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use","volume":"94","author":"Leweke","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.expneurol.2010.03.018_bib63","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.npp.1300838","article-title":"Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice","volume":"31","author":"Long","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0705931","article-title":"Marijuana and cannabinoid regulation of brain reward circuits","volume":"143","author":"Lupica","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib65","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12035-007-8004-x","article-title":"The endocannabinoid system and extinction learning","volume":"36","author":"Lutz","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF03033802","article-title":"What is the mechanism whereby cannabis use increases risk of psychosis?","volume":"14","author":"Luzi","year":"2008","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2010.03.018_bib67","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1046\/j.1460-9568.2002.01957.x","article-title":"Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour","volume":"15","author":"Maccarrone","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib68","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/0269881106063816","article-title":"Effects of the cannabinoid CB1 receptor agonist CP55, 940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys","volume":"20","author":"Madsen","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbr.2005.07.009","article-title":"The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats","volume":"166","author":"Malone","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2010.03.018_bib70","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.pbb.2004.02.010","article-title":"The effect of SR 141716 and apomorphine on sensorimotor gating in Swiss mice","volume":"77","author":"Malone","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2010.03.018_bib71","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neuroscience.2007.10.043","article-title":"Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats","volume":"152","author":"Malone","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.03.018_bib72","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF02247436","article-title":"Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats","volume":"124","author":"Mansbach","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2010.03.018_bib73","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.neuropharm.2007.12.011","article-title":"Antagonistic cannabinoid CB1\/dopamine D2 receptor interactions in striatal CB1\/D2 heteromers. A combined neurochemical and behavioral analysis","volume":"54","author":"Marcellino","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib74","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.nbd.2009.01.014","article-title":"Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis","volume":"34","author":"Marchalant","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2010.03.018_bib75","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2010.03.018_bib76","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","article-title":"Involvement of CB1 cannabinoid receptors in emotional behaviour","volume":"159","author":"Martin","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2010.03.018_bib77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00213-002-1240-x","article-title":"Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat","volume":"165","author":"Martin","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2010.03.018_bib78","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00406-006-0665-3","article-title":"(AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population","volume":"256","author":"Martinez-Gras","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib79","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FBP.0b013e3282ee7b44","article-title":"Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect","volume":"18","author":"McLaughlin","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib80","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.161.6.975","article-title":"Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder","volume":"161","author":"Meltzer","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib81","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/npp.2008.98","article-title":"Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels","volume":"34","author":"Micale","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib82","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2010.03.018_bib83","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice","volume":"512","author":"Moreira","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib84","doi-asserted-by":"crossref","first-page":"625469","DOI":"10.1155\/2009\/625469","article-title":"Antiaversive effects of cannabinoids: is the periaqueductal gray involved?","volume":"2009","author":"Moreira","year":"2009","journal-title":"Neural Plast."},{"key":"10.1016\/j.expneurol.2010.03.018_bib85","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.physbeh.2009.04.023","article-title":"Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission","volume":"98","author":"Morrish","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2010.03.018_bib86","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pbb.2006.05.018","article-title":"Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice","volume":"84","author":"Nagai","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2010.03.018_bib87","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00221-006-0503-x","article-title":"Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia","volume":"172","author":"Newell","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.expneurol.2010.03.018_bib88","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.299.13.1547","article-title":"Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2010.03.018_bib89","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2005.03.036","article-title":"Systemic administration of WIN 55, 212-2 increases norepinephrine release in the rat frontal cortex","volume":"1046","author":"Oropeza","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2010.03.018_bib90","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"145","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib91","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1073858408317242","article-title":"Cognitive role of neurogenesis in depression and antidepressant treatment","volume":"14","author":"Perera","year":"2008","journal-title":"Neuroscientist"},{"key":"10.1016\/j.expneurol.2010.03.018_bib92","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib93","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s002130050987","article-title":"Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils","volume":"144","author":"Poncelet","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2010.03.018_bib94","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2005.05.014","article-title":"WIN 55, 212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT(3) receptor function","volume":"517","author":"Przegalinski","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib95","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbr.2009.05.013","article-title":"Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats","volume":"203","author":"Reich","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2010.03.018_bib96","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1471-4159.2009.05898.x","article-title":"Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine","volume":"108","author":"Rodriguez-Gaztelumendi","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.03.018_bib97","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1440-1681.2007.04576.x","article-title":"Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test","volume":"34","author":"Roohbakhsh","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib98","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1523\/JNEUROSCI.5346-07.2008","article-title":"Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum","volume":"28","author":"Rossi","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.018_bib99","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1098-2396(200001)35:1<8::AID-SYN2>3.0.CO;2-Y","article-title":"In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments","volume":"35","author":"Rubino","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2010.03.018_bib129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1385\/MN:33:3:199","article-title":"Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade","volume":"33","author":"Rubino","year":"2006","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2007.06.024","article-title":"CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour","volume":"54","author":"Rubino","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib101","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cercor\/bhm161","article-title":"Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex","volume":"18","author":"Rubino","year":"2008","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.expneurol.2010.03.018_bib102","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1038\/sj.npp.1301664","article-title":"Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates","volume":"33","author":"Rubino","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib103","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12640-009-9031-3","article-title":"The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex","volume":"15","author":"Rubino","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2010.03.018_bib104","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuropharm.2007.08.011","article-title":"The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition","volume":"54","author":"Scherma","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00008877-200202000-00003","article-title":"The cannabinoid agonist WIN 55, 212-2 reduces sensorimotor gating and recognition memory in rats","volume":"13","author":"Schneider","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib106","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2007.08.008","article-title":"No association of CNR1 gene variations with susceptibility to schizophrenia","volume":"426","author":"Seifert","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2010.03.018_bib107","first-page":"1","article-title":"Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats","author":"Seillier","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib108","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0031-9384(02)00931-9","article-title":"Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia","volume":"77","author":"Sesack","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2010.03.018_bib109","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0006-8993(90)91146-8","article-title":"In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other","volume":"527","author":"Sesack","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2010.03.018_bib110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/09540260902782802","article-title":"Cannabinoids and psychosis","volume":"21","author":"Sewell","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib111","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00008877-200312000-00001","article-title":"Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice","volume":"14","author":"Shearman","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib112","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.287.9.1123","article-title":"Cognitive functioning of long-term heavy cannabis users seeking treatment","volume":"287","author":"Solowij","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2010.03.018_bib113","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.euroneuro.2009.09.004","article-title":"Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats","volume":"20","author":"Spano","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib114","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2004.00806.x","article-title":"Early adolescent cannabis exposure and positive and negative dimensions of psychosis","volume":"99","author":"Stefanis","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.expneurol.2010.03.018_bib115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psyneuen.2007.09.008","article-title":"Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice","volume":"33","author":"Steiner","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib116","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.tpj.6500466","article-title":"Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice","volume":"8","author":"Steiner","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.expneurol.2010.03.018_bib117","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2008.05.020","article-title":"Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests","volume":"589","author":"Takahashi","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib118","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.euroneuro.2008.11.004","article-title":"Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray","volume":"19","author":"Terzian","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib119","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions","volume":"138","author":"Tzavara","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib120","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuropharm.2004.01.003","article-title":"Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors","volume":"46","author":"Uriguen","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2010.03.018_bib121","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S1461145708009371","article-title":"Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia","volume":"12","author":"Vigano","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2010.03.018_bib122","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-008-1148-1","article-title":"Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats","volume":"198","author":"Wegener","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2010.03.018_bib123","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bmj.325.7374.1199","article-title":"Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study","volume":"325","author":"Zammit","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.expneurol.2010.03.018_bib124","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2010.03.018_bib126","first-page":"485","article-title":"Antipsychotic effect of cannabidiol","volume":"56","author":"Zuardi","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.018_bib127","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0269881106060967","article-title":"Cannabidiol monotherapy for treatment-resistant schizophrenia","volume":"20","author":"Zuardi","year":"2006","journal-title":"J. Psychopharmacol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610001032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610001032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T20:14:34Z","timestamp":1558988074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488610001032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0014488610001032"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2010.03.018","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}